[PHAS] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[PHAS] PhaseBio Pharmaceuticals, Inc.
Announcement Date
29-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -18.38%
YoY- -208.63%
Quarter Report
PHAS's Result
PHAS's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 703 653 257 411 0 0 0 -
PBT -9,232 -7,293 -4,868 -7,901 -6,674 -4,403 -2,535 137.26%
Tax 469 317 2,975 -2,012 -1,120 -121 1,034 -41.05%
NP -9,232 -7,293 -4,868 -7,901 -6,674 -4,403 -2,535 137.26%
Tax Rate - - - - - - - -
Total Cost 9,935 7,946 5,125 8,312 6,674 4,403 2,535 149.19%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -1,313.23 -1,116.85 -1,894.16 -1,922.38 0.00 0.00 0.00 -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -0.33 -0.30 -0.26 -0.40 -0.34 -0.36 -0.20 39.76%
EPS Diluted -0.33 -0.30 -0.26 -0.40 -0.34 -0.36 -0.20 39.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.